Live feed07:00:00·5hPRReleasevia QuantisnowRedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's DiseaseByQuantisnow·Wall Street's wire, on your screen.CPIX· Cumberland Pharmaceuticals Inc.RDHL· Redhill Biopharma Ltd.Health Care
